medical cannabis
medical cannabis · page 11
- Medical Cannabis
Implementation Questionable: Federal Drug Commissioner Calls for Stricter Rules on Cannabis Medicine
This article is also available in German Germany’s new Federal Drug Commissioner, Prof Dr Hendrik Streeck (CDU), who in June had spoken only vaguely about the partial legalisation of cannabis, has since taken a sharper stance.
- Companies
Script Assist Unveils Ground-Up Rebuild of UK Medical Cannabis Software
Script Assist, the SaaS platform now used by some of the UK’s leading medical cannabis clinics and prescribing doctors, is set to launch a major ground-up overhaul of its platform.
- Prescribers & Clinics
UK Patient Data Exposed Amid Clinic Data Breach
Originally published on Cannabis Health A UK medical cannabis clinic is carrying out investigations after a substantial amount of patients’ information was leaked in a major data breach.
- Interviews
Legal Medicine Shouldn’t Make You Feel Like a Criminal at the Airport
The UK’s Border Force and airport security services have been on high alert for cannabis coming into and out of the country for some time, following a significant spike in seizures.
- Medical Cannabis
German Health Insurance Companies No Longer Want to Cover the Costs of Cannabis Flower
In Germany, the partial legalisation of cannabis has opened up a new telemedicine market. Instead of visiting a doctor in person, patients can now request prescriptions online, with cannabis flowers sent directly to patients via specialist pharmacies.
- Legal Analysis
Germany’s Medical Market Continues Record Growth in the Face of Clampdown
The blistering growth of Germany’s medical cannabis sector showed no signs of abating through the second quarter of 2025, with imports rising another 15% to hit new records.
- Medical Cannabis
Why France’s Strict Medical Cannabis Plans Could be its Secret Weapon
Augur Associates and Newsweed, two organisations at the forefront of the ongoing developments in the region, believe that the incoming system not only sidesteps many of the issues other countries have faced in the implementation phase, but that it could reestablish the country’s standing as a model of inspiration for neighbouring states and prospective forthcoming EU supra-regulation.
- Medical Cannabis
Not on Our Watch: Releaf Pushes Back Against Rushed Cannabis Prescribing
The British Medical Association (BMA), which represents tens of thousands of General Practitioners in the UK, this week threatened new strike action amid increasing tensions with the Starmer government.
- Interviews
Why Curaleaf Laboratories Believes the UK Medical Cannabis Market Is Still Just Getting Started
As the UK’s medical cannabis patient population pushes past an estimated 60,000, questions about market maturity, patient access, and regulatory reform are more pressing than ever.
- UK & Europe
Landmark Turkish Bill Legalises Low THC Cannabis Sales in Pharmacies
As reported by Turkiye Today, the Turkish parliament has now passed the proposed legislative package, introducing significant reforms to the healthcare system, including the regulated sale of medical cannabis in pharmacies.
- Industry Trends
Why the UK’s Steady Medical Cannabis Market Growth Is Its Biggest Advantage
Though less explosive than markets like Germany or Australia, the UK has continued to evolve in a more controlled manner, enabling it to largely avoid the scrutiny and intervention that have accompanied rapid expansion elsewhere.
- Medical Cannabis
Czech Republic to Decriminalise Cannabis from 2026 — But Medical Exports Already Booming
The Czech Republic has been pursuing a more relaxed cannabis policy for some time. In early June, the lower house of parliament approved a draft law amounting to partial legalisation. The Senate followed suit at the start of July, meaning cannabis will be fully decriminalised from 1 January next year.
